{"id":2384,"date":"2026-08-25T10:00:00","date_gmt":"2026-08-25T01:00:00","guid":{"rendered":"https:\/\/www.lifescience.shokubai.co.jp\/?post_type=news&#038;p=2384"},"modified":"2026-08-25T09:16:03","modified_gmt":"2026-08-25T00:16:03","slug":"poster-presentation-at-the-11th-annual-meeting-of-the-nucleic-acids-therapeutics-society-of-japan-development-of-chromatographic-separation-methods-for-the-purification-of-single-guide-rna-therapeu","status":"publish","type":"news","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2384\/","title":{"rendered":"Poster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: &#8220;Development of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics&#8221; (Presented in Collaboration with YMC CO., LTD.)"},"content":{"rendered":"\n<p class=\"has-medium-font-size wp-block-paragraph\">At the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Dejima Messe Nagasaki from July 7th to 9th, YMC Co., Ltd. delivered a poster presentation on our joint research. NIPPON SHOKUBAI CO., LTD. participated as a co-presenter, collaborating on the poster preparation and joint Q&amp;A sessions. We are pleased to introduce the content published in the meeting&#8217;s abstract collection.<\/p>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-1\" style=\"color:#026745\">Presentation<\/h2>\n\n\n\n<figure class=\"wp-block-table is-style-regular\"><table><tbody><tr><td><strong>Title<\/strong><\/td><td>Development of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics<\/td><\/tr><tr><td><strong><strong>Affiliations<\/strong><\/strong><\/td><td>R&amp;D DEPT., YMC CO., LTD.,<br>Health &amp; Medical Business Division, NIPPON SHOKUBAI CO., LTD.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-2\" style=\"color:#026745\">Background<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Demand for highly pure single-guide RNA (sgRNA) is increasing as its use in clinical applications grows. Ion-pair reversed-phase liquid chromatography (IP-RP-LC) using alkylamine ion-pair reagents and hexafluoroisopropanol (HFIP) has been widely used for high-resolution separation of long (approximately 100-mer) oligonucleotides, enabling the removal of closely related impurities from synthetic sgRNA. This method is, however, hardly applicable to industry-scale purification of long oligonucleotides due to the high cost and environmental burden of HFIP; thus, an alternative method is required.<\/p>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-3\" style=\"color:#026745\">Research Contents<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">This study aimed to develop an IP-RP-LC method for purifying phosphorothioate (PS)-modified sgRNA without using HFIP or other expensive additives. Previous research indicates that the addition of sodium phosphate buffer to alkylamine mobile phase solutions enhances the separation of long oligonucleotides. Here, we hypothesized that the following two factors are involved in this enhancement: 1) phosphate ions, which may prevent the adsorption of oligonucleotides in the LC system, including the column; 2) sodium ions in the mobile phase, which may stabilize the secondary structure of oligonucleotides. Our data show that the enhanced separation of oligonucleotides by the addition of phosphate buffer is due to sodium ions, rather than to phosphate ions. We observed that a similar enhancement was also caused by another potassium ion. By applying these findings, we established a novel method for separating 100-mer sgRNA from 5\u2019 truncated products and phosphodiester (PO) impurities without using HFIP. This method offers a cost-effective and environmentally favorable solution for the industrial manufacturing of sgRNA drug substances.<\/p>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"748\" height=\"1024\" src=\"https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2026\/08\/\u99ac\u5834\u3055\u30932_kz-1-748x1024.jpg\" alt=\"\" class=\"wp-image-2385\" srcset=\"https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2026\/08\/\u99ac\u5834\u3055\u30932_kz-1-748x1024.jpg 748w, https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2026\/08\/\u99ac\u5834\u3055\u30932_kz-1-219x300.jpg 219w, https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2026\/08\/\u99ac\u5834\u3055\u30932_kz-1-768x1052.jpg 768w, https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2026\/08\/\u99ac\u5834\u3055\u30932_kz-1-1122x1536.jpg 1122w, https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2026\/08\/\u99ac\u5834\u3055\u30932_kz-1.jpg 1478w\" sizes=\"auto, (max-width: 748px) 100vw, 748px\" \/><figcaption class=\"wp-element-caption\">Takeshi Baba, Health &amp; Medical Business Division, NIPPON SHOKUBAI CO., LTD.<\/figcaption><\/figure>\n<\/div>\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-4\" style=\"color:#026745\">Meeting Information<\/h2>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><tbody><tr><td>Name<\/td><td>\u00a0The 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan<\/td><\/tr><tr><td>Meeting<\/td><td>July 7<sup>th<\/sup> (Tue) \u2013 July 9<sup>th<\/sup> (Thu), 2026<\/td><\/tr><tr><td>Venue<\/td><td>Dejima Messe Nagasaki<\/td><\/tr><tr><td>Official website<\/td><td>\u00a0<a href=\"https:\/\/www.natsj.jp\/2026\/natsj11\" target=\"_blank\" rel=\"noopener\" title=\"\">https:\/\/www.natsj.jp\/2026\/natsj11<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"featured_media":0,"template":"","news_category":[16],"class_list":["post-2384","news","type-news","status-publish","hentry","news_category-technical-information-en"],"acf":{"blank_url":"","pdf_url":null,"select_link":"single_link"},"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.3 - aioseo.com -->\n\t<meta name=\"description\" content=\"At the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Dejima Messe Nagasaki from July 7th to 9th, YMC Co., Ltd. delivered a poster presentation on our joint research. NIPPON SHOKUBAI CO., LTD. participated as a co-presenter, collaborating on the poster preparation and joint Q&amp;A sessions. We are pleased to\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2384\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.3\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"NIPPON SHOKUBAI | Nippon Shokubai\u2019s Health &amp; Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Poster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: \u201cDevelopment of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics\u201d (Presented in Collaboration with YMC CO., LTD.) | NIPPON SHOKUBAI\" \/>\n\t\t<meta property=\"og:description\" content=\"At the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Dejima Messe Nagasaki from July 7th to 9th, YMC Co., Ltd. delivered a poster presentation on our joint research. NIPPON SHOKUBAI CO., LTD. participated as a co-presenter, collaborating on the poster preparation and joint Q&amp;A sessions. We are pleased to\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2384\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-08-25T01:00:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-08-25T00:16:03+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Poster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: \u201cDevelopment of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics\u201d (Presented in Collaboration with YMC CO., LTD.) | NIPPON SHOKUBAI\" \/>\n\t\t<meta name=\"twitter:description\" content=\"At the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Dejima Messe Nagasaki from July 7th to 9th, YMC Co., Ltd. delivered a poster presentation on our joint research. NIPPON SHOKUBAI CO., LTD. participated as a co-presenter, collaborating on the poster preparation and joint Q&amp;A sessions. We are pleased to\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/2384\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#listItem\",\"position\":1,\"name\":\"\\u5bb6\",\"item\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/#listItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/technical-information-en\\\/#listItem\",\"name\":\"Technical Info\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#listItem\",\"name\":\"\\u5bb6\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/technical-information-en\\\/#listItem\",\"position\":3,\"name\":\"Technical Info\",\"item\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/technical-information-en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/2384\\\/#listItem\",\"name\":\"Poster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: &#8220;Development of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics&#8221; (Presented in Collaboration with YMC CO., LTD.)\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/2384\\\/#listItem\",\"position\":4,\"name\":\"Poster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: &#8220;Development of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics&#8221; (Presented in Collaboration with YMC CO., LTD.)\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/technical-information-en\\\/#listItem\",\"name\":\"Technical Info\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#organization\",\"name\":\"\\u682a\\u5f0f\\u4f1a\\u793e\\u65e5\\u672c\\u89e6\\u5a92\",\"description\":\"Nippon Shokubai\\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.\",\"url\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/2384\\\/#webpage\",\"url\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/2384\\\/\",\"name\":\"Poster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: \\u201cDevelopment of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics\\u201d (Presented in Collaboration with YMC CO., LTD.) | NIPPON SHOKUBAI\",\"description\":\"At the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Dejima Messe Nagasaki from July 7th to 9th, YMC Co., Ltd. delivered a poster presentation on our joint research. NIPPON SHOKUBAI CO., LTD. participated as a co-presenter, collaborating on the poster preparation and joint Q&A sessions. We are pleased to\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/2384\\\/#breadcrumblist\"},\"datePublished\":\"2026-08-25T10:00:00+09:00\",\"dateModified\":\"2026-08-25T09:16:03+09:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/\",\"name\":\"\\u682a\\u5f0f\\u4f1a\\u793e\\u65e5\\u672c\\u89e6\\u5a92\",\"description\":\"Nippon Shokubai\\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Poster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: \u201cDevelopment of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics\u201d (Presented in Collaboration with YMC CO., LTD.) | NIPPON SHOKUBAI","description":"At the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Dejima Messe Nagasaki from July 7th to 9th, YMC Co., Ltd. delivered a poster presentation on our joint research. NIPPON SHOKUBAI CO., LTD. participated as a co-presenter, collaborating on the poster preparation and joint Q&A sessions. We are pleased to","canonical_url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2384\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2384\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#listItem","position":1,"name":"\u5bb6","item":"https:\/\/www.lifescience.shokubai.co.jp\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/#listItem","position":2,"name":"News","item":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/technical-information-en\/#listItem","name":"Technical Info"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#listItem","name":"\u5bb6"}},{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/technical-information-en\/#listItem","position":3,"name":"Technical Info","item":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/technical-information-en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2384\/#listItem","name":"Poster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: &#8220;Development of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics&#8221; (Presented in Collaboration with YMC CO., LTD.)"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2384\/#listItem","position":4,"name":"Poster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: &#8220;Development of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics&#8221; (Presented in Collaboration with YMC CO., LTD.)","previousItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/technical-information-en\/#listItem","name":"Technical Info"}}]},{"@type":"Organization","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#organization","name":"\u682a\u5f0f\u4f1a\u793e\u65e5\u672c\u89e6\u5a92","description":"Nippon Shokubai\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.","url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/"},{"@type":"WebPage","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2384\/#webpage","url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2384\/","name":"Poster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: \u201cDevelopment of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics\u201d (Presented in Collaboration with YMC CO., LTD.) | NIPPON SHOKUBAI","description":"At the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Dejima Messe Nagasaki from July 7th to 9th, YMC Co., Ltd. delivered a poster presentation on our joint research. NIPPON SHOKUBAI CO., LTD. participated as a co-presenter, collaborating on the poster preparation and joint Q&A sessions. We are pleased to","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#website"},"breadcrumb":{"@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2384\/#breadcrumblist"},"datePublished":"2026-08-25T10:00:00+09:00","dateModified":"2026-08-25T09:16:03+09:00"},{"@type":"WebSite","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#website","url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/","name":"\u682a\u5f0f\u4f1a\u793e\u65e5\u672c\u89e6\u5a92","description":"Nippon Shokubai\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.","inLanguage":"en-US","publisher":{"@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"NIPPON SHOKUBAI | Nippon Shokubai\u2019s Health &amp; Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.","og:type":"article","og:title":"Poster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: \u201cDevelopment of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics\u201d (Presented in Collaboration with YMC CO., LTD.) | NIPPON SHOKUBAI","og:description":"At the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Dejima Messe Nagasaki from July 7th to 9th, YMC Co., Ltd. delivered a poster presentation on our joint research. NIPPON SHOKUBAI CO., LTD. participated as a co-presenter, collaborating on the poster preparation and joint Q&amp;A sessions. We are pleased to","og:url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2384\/","article:published_time":"2026-08-25T01:00:00+00:00","article:modified_time":"2026-08-25T00:16:03+00:00","twitter:card":"summary_large_image","twitter:title":"Poster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: \u201cDevelopment of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics\u201d (Presented in Collaboration with YMC CO., LTD.) | NIPPON SHOKUBAI","twitter:description":"At the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Dejima Messe Nagasaki from July 7th to 9th, YMC Co., Ltd. delivered a poster presentation on our joint research. NIPPON SHOKUBAI CO., LTD. participated as a co-presenter, collaborating on the poster preparation and joint Q&amp;A sessions. We are pleased to"},"aioseo_meta_data":{"post_id":"2384","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-08-06 06:19:14","updated":"2026-08-25 02:10:04","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/\" title=\"\u5bb6\">\u5bb6<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/\" title=\"News\">News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/technical-information-en\/\" title=\"Technical Info\">Technical Info<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tPoster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: \u201cDevelopment of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics\u201d (Presented in Collaboration with YMC CO., LTD.)\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"\u5bb6","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/"},{"label":"News","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/"},{"label":"Technical Info","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/technical-information-en\/"},{"label":"Poster Presentation at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan: &#8220;Development of Chromatographic Separation Methods for the Purification of Single-Guide RNA Therapeutics&#8221; (Presented in Collaboration with YMC CO., LTD.)","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2384\/"}],"_links":{"self":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/2384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":3,"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/2384\/revisions"}],"predecessor-version":[{"id":2390,"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/2384\/revisions\/2390"}],"wp:attachment":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/media?parent=2384"}],"wp:term":[{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news_category?post=2384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}